Search

everythinglearnresearchcommunity

for

Search:↓

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Minoxidil shows promise for alopecia areata, but more research is needed before it can be recommended as a primary treatment.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.

Healthy mitochondria in skin cells are essential for proper hair growth and skin cell interaction in mice.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Cannabinoids may help treat various skin conditions.

Autophagy helps keep skin healthy and may improve treatments for skin diseases.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Sheep-derived factors improve human hair cell clustering, which may help hair growth.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Stem cell therapy shows promise in improving burn wound healing.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Minoxidil can cause a skin reaction called ALEP.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Stress hormones and autoimmune reactions can cause hair loss.